🇺🇸 FDA
Patent

US 12285472

Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof

granted A61KA61K2039/55555A61K2039/6006

Quick answer

US patent 12285472 (Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof) held by The Regents of the University of California expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/55555, A61K2039/6006, A61K35/12, A61K39/0008